
In a recent study published in the journal Emerging Infectious Diseases, researchers evaluated the resilience of the highly pathogenic avian influenza A (H5N1) virus in milk under pasteurization-like temperatures and assessed the effectiveness of thermal inactivation.
Different volumes of the spiked samples (200 μL, 20 μL, and 2 μL) were used to assess how volume might influence the effectiveness of heat treatments. Additionally, the PR8 strain was tested in both pasteurized and unpasteurized milk to examine the impact of preheating milk at 37°C for 1 minute before exposure to HTST conditions. After the heat treatments, the samples were adjusted to a final volume of 200 μL and titrated to determine viral viability.
The study further explored the impact of different types of milk and storage temperatures on virus stability. Pasteurized, unpasteurized colostrum and mature milk were spiked with viruses and stored at different temperatures for up to four days. The viruses remained infectious for more than four days in unpasteurized milk at temperatures below 63°C, where viral inactivation occurred within 24 hours. Unpasteurized colostrum milk showed enhanced viral inactivation, possibly due to the presence of immunoglobulins, which provide a natural defense.
Nevertheless, a critical limitation is that spiking viruses into milk does not fully replicate the dynamics of a natural infection scenario. Enveloped viruses, such as influenza, are generally less stable than non-enveloped viruses, which have been more thoroughly studied in similar settings. This limitation underscores the need for further investigation into how viral inactivation in milk behaves under real-world conditions.Despite these findings, it is important to recognize that the presence of viral Ribonucleic Acid (RNA) in milk samples without viable viruses may be due to the sensitivity of modern detection methods rather than actual risk. Previous studies investigating HTST-like temperature conditions have produced mixed results. For instance, one study found that complete viral inactivation occurred only at 105°C, whereas another study demonstrated total inactivation using HTST conditions. These conflicting results highlight the complexity of viral resilience under varying thermal conditions. The current study adds valuable insight but must be interpreted in the context of these prior findings, emphasizing the importance of further research in this area.
The evidence indicates that HTST pasteurization can effectively inactivate the influenza virus, reducing the risk in milk supplies. However, due to the experimental limitations discussed earlier, caution is still warranted, and definitively ruling out the presence of live virus may require multiple blind passages in eggs, as is standard in surveillance studies. The study’s findings, particularly with the PR8 strain, could serve as a valuable reference for evaluating commercial pasteurization processes. Nonetheless, the study highlights that further real-world testing is essential to ensure the robustness of these processes under industry conditions. Understanding the factors influencing virus survival in milk will help guide interventions to improve milk safety and address concerns about emerging viral threats.